or
forgot password

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography


N/A
18 Years
N/A
Not Enrolling
Both
Brain Tumor

Thank you

Trial Information

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-fluorothymidine Positron Emission Tomography


In this study, 35 patients will be selected to undergoing sequential imaging with FLT-PET.
Prior to surgical resection, patients will undergo a preliminary FLT-PET. Additional FLT
scans for a maximum of four scans.


Inclusion Criteria:



- 18 years or older

- Women must not be pregnant or breast feeding

- Histologic or strong radiologic suspicion of high grade malignant glioma or
ogliometastatic tumor(s)

Exclusion Criteria:

- May not have received previous therapy for their malignancy

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Principal Investigator

Jennifer Holter, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Assistant Professor

Authority:

United States: Food and Drug Administration

Study ID:

FLT- Brain Study

NCT ID:

NCT00775320

Start Date:

October 2008

Completion Date:

Related Keywords:

  • Brain Tumor
  • Brain scan
  • Brain Neoplasms

Name

Location
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma  73104